Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)

China · Delayed Price · Currency is CNY

10.12

+0.52 (5.42%)

Aug 14, 2026, 3:00 PM CST

Shenzhen YHLO Biotech Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,791	1,811	2,012	2,053	3,981	1,178
Revenue Growth	-10.38%	-9.99%	-2.02%	-48.42%	237.96%	17.91%
Gross Profit	1,149	1,150	1,292	1,104	2,044	647.73
Operating Income	179.45	189.68	335.99	251.62	1,146	210.85
Net Income	31.14	23.34	301.53	355.01	1,012	204.75
Earnings Per Share	0.05	0.04	0.53	0.62	1.78	0.38
EPS Growth	-88.33%	-92.45%	-14.52%	-65.17%	368.42%	-8.28%

Revenue by Geography

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
China	1,449
Overseas	315.75
Total	1,764

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	661.96	686.81	716.93	710.85	1,433	495
Total Debt	939.2	895.91	905.79	557.6	473.55	233.69
Net Cash (Debt)	-277.25	-209.11	-188.86	153.25	959.74	261.31
Net Cash Growth	-	-	-	-84.03%	267.28%	-
Net Cash Per Share	-0.46	-0.36	-0.33	0.27	1.69	0.48

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	506.11	421.85	529.9	-73.19	1,583	259.62
Capital Expenditures	-411.51	-359.24	-593.31	-662.71	-565.37	-372.66
Free Cash Flow	94.59	62.61	-63.41	-735.9	1,018	-113.04
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	64.18%	63.51%	64.20%	53.77%	51.34%	54.99%
Operating Margin	10.02%	10.48%	16.70%	12.26%	28.79%	17.90%
Pretax Margin	5.79%	5.22%	15.49%	16.27%	29.81%	19.34%
Profit Margin	1.74%	1.29%	14.99%	17.29%	25.42%	17.38%
FCF Margin	5.28%	3.46%	-3.15%	-35.84%	25.57%	-9.60%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	0.021	0.021	0.210	0.273	0.450	0.286
Dividend Per Share Growth	-90.00%	-90.00%	-23.08%	-39.33%	57.51%	-
Dividend Yield	0.22%	0.15%	1.35%	1.23%	2.41%	1.24%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	197.00	347.62	29.88	36.60	11.01	68.34
Forward PE	29.33	21.63	16.84	27.31	17.99	34.64
P/FCF Ratio	61.13	129.60	-	-	10.95	-
PS Ratio	3.23	4.48	4.48	6.33	2.80	11.88